US20020160012A1 - Vaccine chip technology exploiting immunostimulating fragment of TGF-BETA - Google Patents

Vaccine chip technology exploiting immunostimulating fragment of TGF-BETA Download PDF

Info

Publication number
US20020160012A1
US20020160012A1 US09/822,873 US82287301A US2002160012A1 US 20020160012 A1 US20020160012 A1 US 20020160012A1 US 82287301 A US82287301 A US 82287301A US 2002160012 A1 US2002160012 A1 US 2002160012A1
Authority
US
United States
Prior art keywords
fragment
immunogenic composition
tgf
immunogenic
conjugated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/822,873
Inventor
Peter Kaastrup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VACCINE CHIP TECHNOLOGY APS
Original Assignee
VACCINE CHIP TECHNOLOGY APS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DKPA200000540 priority Critical
Priority to DKPA200000540 priority
Priority to US24697300P priority
Application filed by VACCINE CHIP TECHNOLOGY APS filed Critical VACCINE CHIP TECHNOLOGY APS
Priority to US09/822,873 priority patent/US20020160012A1/en
Assigned to VACCINE CHIP TECHNOLOGY APS reassignment VACCINE CHIP TECHNOLOGY APS ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KAASTRUP, PETER
Publication of US20020160012A1 publication Critical patent/US20020160012A1/en
Abandoned legal-status Critical Current

Links